HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes

Nature
K L CollinsD Baltimore

Abstract

Cytotoxic T lymphocytes (CTLs) lyse virally infected cells that display viral peptide epitopes in association with major histocompatibility complex (MHC) class I molecules on the cell surface. However, despite a strong CTL response directed against viral epitopes, untreated people infected with the human immunodeficiency virus (HIV-1) develop AIDS. To resolve this enigma, we have examined the ability of CTLs to recognize and kill infected primary T lymphocytes. We found that CTLs inefficiently lysed primary cells infected with HIV-1 if the viral nef gene product was expressed. Resistance of infected cells to CTL killing correlated with nef-mediated downregulation of MHC class I and could be overcome by adding an excess of the relevant HIV-1 epitope as soluble peptide. Thus, Nef protected infected cells by reducing the epitope density on their surface. This effect of nef may allow evasion of CTL lysis by HIV-1-infected cells.

References

Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·B D WalkerR T Schooley
Dec 1, 1989·AIDS Research and Human Retroviruses·T KerkauE Wecker
Jul 10, 1996·JAMA : the Journal of the American Medical Association·T R O'BrienJ J Goedert
Oct 1, 1996·Immunity·M JondalJ Reimann
Jan 7, 1997·Proceedings of the National Academy of Sciences of the United States of America·G PantaleoA S Fauci

❮ Previous
Next ❯

Citations

Oct 31, 2002·Human Psychopharmacology·Kurt Heininger
Aug 14, 2001·European Journal of Immunology·A H ChangF R Jirik
Aug 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A Cerny, F V Chisari
May 8, 2003·Journal of Biosciences·Alison L GreenwayMichael Lidman
Oct 20, 2009·Immunogenetics·Vilasack ThammavongsaMalini Raghavan
Jul 16, 2008·Apoptosis : an International Journal on Programmed Cell Death·Devon J ShedlockDavid B Weiner
Feb 22, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·John L FosterJ Victor Garcia
Sep 14, 2002·Current Infectious Disease Reports·Stephen A. Migueles, Mark Connors
Jul 20, 2002·Current Infectious Disease Reports·M. Patricia D'SouzaMargaret I. Johnston
Oct 16, 2001·Immunology Letters·G Marodon
Sep 29, 1999·Immunology Today·H Soudeyns, G Pantaleo
Oct 15, 1998·Nature Medicine·A D HislopA Suhrbier
Apr 20, 2001·Nature·A J McMichael, S L Rowland-Jones
Aug 24, 2005·Nature Immunology·Paul Klenerman, Ann Hill
Aug 3, 2004·Nature Reviews. Immunology·Philip J R Goulder, David I Watkins
Mar 24, 2007·Nature Reviews. Immunology·Oliver T FacklerOlivier Schwartz
Jun 6, 2009·Nature Reviews. Immunology·Ted H Hansen, Marlene Bouvier
Feb 26, 2011·Nature Reviews. Immunology·Marcus AltfeldNina Bhardwaj
May 11, 2002·Nature Reviews. Immunology·Andrew McMichael, Tomâs Hanke
Jun 19, 2012·Nature Structural & Molecular Biology·Xiaofei JiaYong Xiong
Mar 21, 2007·Immunology and Cell Biology·Becca Asquith, Charles R M Bangham
Dec 3, 1999·European Journal of Clinical Investigation·F SilvestrisF Dammacco
Aug 30, 2000·European Journal of Clinical Investigation·W KampH S Nottet
Aug 30, 2000·European Journal of Clinical Investigation·T K Howcroft
Jun 3, 1999·The New England Journal of Medicine·K L Collins, G J Nabel
Jul 25, 2012·Proceedings of the National Academy of Sciences of the United States of America·Ushani S RajapaksaXiao-Ning Xu
May 16, 1998·The Journal of Experimental Medicine·R T GandhiD Baltimore
Dec 8, 2004·The Journal of Experimental Medicine·Adrian F OchsenbeinPhilip D Greenberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.